Sleep medication use in Canadian seniors

Canadian Journal of Clinical Pharmacology

Volumn 16, Issue 3, 2009, Pages

  Ineke Neutel, C ^a   Patten, Scott B ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Comorbidity; Elderly; Quality of sleep; Sleep medication

Indexed keywords

NON PRESCRIPTION DRUG;

ADULT; AGED; AGING; ARTICLE; CANADA; CHRONIC DISEASE; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SEX DIFFERENCE;

EID: 73249117837     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. State-of-the-Science Panel. National Institutes of Health State-of the-Science Conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. http://consensus.nih.gov/2005/ 2005InsomniaSOS026html.htm
2. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ 2000;162:216-20.
3. Pagel JF, Parnes BL. Medications for the Treatment of Sleep Disorders: An Overview. Prim Care Companion J Clin Psychiatry 2001;3:118-125.
4. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000;23 Suppl 1:S23-30.
5. Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness J. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. Euro J Clin Pharmacol 2009;65:295-301.
6. Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev. 2000; 4:551-581.
7. Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003;26:261-82.
8. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225-33.
9. Busto UE, Sproule BA, Knight K, Herrmann N. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 2001;8:213-21.
10. Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 2005;56:332-43.
11. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S. The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry 1999;14:851-7.
12. Roehrs T, Hollebeek E, Drake C, Roth T. Substance use for insomnia in Metropolitan Detroit. J Psychosom Res 2002;53:571-6.
13. Bartlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R. Longitudinal patterns of new Benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf 2004;13:669-82.
14. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:83-121.
15. Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 2005;17:189-97.
16. Barbui C, Gregis M, Zappa M. A cross-sectional audit of benzodiazepine use among general practice patients. Acta Psychiatr Scand 1998;7:153-156.
17. Balkrishnan R, Rasu RS, Rajagopalan R. Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States. Sleep 2005;28:715-9.
18. Ohayon MM, Caulet M. Insomnia and psychotropic drug consumption. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:421-31.
19. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepines use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Pharmacol 2001;57:419-425.
20. Neutel CI, Walop W. Drug utilization by men and women: Why the difference? Drug Information Journal 2005;39:299-310.
21. DesMeules M, Stewart D, editors. Women's health surveillance report. A multi-dimensional look at the health of Canadian women. Ottawa, Canada: Health Canada, 2003.
22. Mah L, Upshur RE. Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract 2002; http://www.biomedcentral.com/1471-2296/3/9:
23. Krueger PM, Friedman EM. Sleep duration in the United States: A cross-sectional population-based study. American Journal of Epidemiology 2009;169:1052-1063.
24. Roehrs T, Burduvali E, Bonahoom A, Drake C, Roth T. Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep 2003;26:981-5.
25. Roehrs T, Papineau K, Rosenthal L, Roth T. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacology 1999;20:279-86.
26. Roth T, Roehrs T. Insomnia: epidemiology, characteristics and consequences. Clin Cornerstone 2003;5:5-15.
27. Mendelson WB, Roth T, Cassella J, et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev 2004;8:7-17.
28. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994;150:1801-1809.
29. Ohayon MM, Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 1996;41:457-64.
30. Ancoli-Israel S, Poceta JS, Stepnowsky C, Martin J, Gehrman P. Identification and treatment of sleep problems in the elderly. Sleep Med Rev 1997;1:3-17.
31. Shochat T, Loredo J, Ancoli-Israel S. Sleep Disorders in the Elderly. Curr Treat Options Neurol 2001;3:19-36.